The Pfizer/BioNTech bivalent COVID-19 vaccine (Original and Omicron BA.4/BA.5) has the FDA’s EUA for use in individuals 5 years and over as a single booster dose administered at least two months ...

A medical worker prepares a dose of the Pfizer-Bivalent coronavirus disease (COVID-19) vaccine. (Eric Gaillard/Reuters) ...

Here’s what that means If the FDA panel’s recommendation is endorsed by the CDC, only a single composition of vaccine – in this case, the updated bivalent ... Pfizer's says its COVID-19 ...

The bivalent vaccine is designed to defend against BA.1, an Omicron subvariant, and an early strain of the novel coronavirus. Pfizer Inc. and Moderna Inc. have been developing their versions of ...

The large inflow of cash from Comirnaty gross profits in 2021-22 has further secured BioNTech's financial health. Outside of BioNTech’s covid-19 vaccine candidates, we think the earliest approval ...

mRNA-1083 consists of components of mRNA-1010, Moderna’s vaccine candidate for seasonal influenza, and mRNA-1283, its next-generation bivalent ... COVID/flu shots, including Pfizer/BioNTech ...

Pfizer’s updated vaccine is authorized for people 12 ... we strongly encourage anyone who is eligible to consider receiving a booster dose with a bivalent COVID-19 vaccine to provide better protection ...

Despite advancements in vaccination and treatment, COVID-19 was responsible for 1.8% of all deaths in the United States during the week of January 4-11, 2025. 1-3 The virus disproportionately affects ...

a research team led by the University of Rochester and RSV vaccine manufacturer Pfizer randomly assigned a subset of participants in the United States and Japan in a 1:1 ratio to receive one dose of ...

A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

A German court found Wednesday that American pharmaceutical giant Pfizer and German firm BioNTech violated a patent to make ...